Zepp Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Zepp Health generated cash of $42,134,413, which is more than the previous year. Cash used in financing activities reached the amount of -$295,038,000 last year. Net change in cash is therefore $3,382,614.
Cash Flow
| 2015 | -6.76M | -4.91M | 214.06M |
|---|---|---|---|
| 2016 | 17.26M | -99.38M | 10.02M |
| 2017 | 238.33M | -38.88M | 20.08M |
| 2018 | 707.60M | -324.84M | 639.17M |
| 2019 | 427.99M | -112.70M | 25.60M |
| 2020 | 157.30M | -206.88M | 564.67M |
| 2021 | -232.43M | -1.06B | 551.07M |
| 2022 | -5.39B | -289.55M | 1.98B |
| 2023 | 42.13M | 7.71M | -295.03M |
ZEPP Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 137.31M | 10.34B | 2.27B | 1.80B | 1.45B | 369.52M | 153.15M | 219.98M | 7.37M |
Operating activities | |||||||||
Net income | -212.11M | -1.98B | 136.95M | 229.70M | 573.37M | 336.32M | 167.09M | 23.94M | -37.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 7.68M | 401.64M | 51.88M | 27.12M | 17.21M | 6.21M | 3.71M | 2.39M | 285K |
Stock-based compensation expense | 8.42M | 336.48M | 83.12M | 65.15M | 55.12M | 0 | 62.78M | 57.73M | 55.99M |
| Deferred income tax benefit | 8.42M | 336.48M | 83.12M | 65.15M | 55.12M | 0 | 62.78M | 57.73M | 55.99M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 42.23M | -998.13M | -239.86M | -131.21M | -130.01M | -26.05M | -13.15M | 2.21M | -17.77M |
Inventories | 51.85M | 1.28B | -83.12M | -410.69M | -432.98M | -234.88M | -57.60M | -103.46M | -52.82M |
Accounts payable | -191.85M | -6.23B | -673.22M | -9.76M | 935.84M | 356.32M | 181.62M | 271.99M | 164.04M |
Cash generated by operating activities | 42.13M | -5.39B | -232.43M | 157.30M | 427.99M | 707.60M | 238.33M | 17.26M | -6.76M |
Investing activities | |||||||||
Purchases Of Investments | -282.14K | -199.20M | -1.07B | -294.28M | -180.92M | -536.18M | -30.11M | -71.81M | -2M |
Investments In Property Plant And Equipment | -1.59M | -67.97M | -53.08M | -84.77M | -46.12M | -69.15M | -21.54M | -11.49M | -2.91M |
Acquisitions Net | 389.92K | 0 | 33.94M | -34.41M | -11.70M | 52.01M | 2.32M | 0 | 0 |
Cash generated by investing activities | 7.71M | -289.55M | -1.06B | -206.88M | -112.70M | -324.84M | -38.88M | -99.38M | -4.91M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 7.03M | 657.06M | 0 | 0 | 0 |
Payments for dividends | 0 | -274.18M | 0 | 0 | -4.53M | 0 | 0 | 0 | 0 |
Repurchases of common stock | -2.50M | -52.85M | -13.76M | 0 | 0 | -8.15M | 0 | 0 | -2.99M |
Repayments of term debt | 0 | 16.14M | -953.38M | -643.12M | 0 | -33.22M | 3.06M | 0 | 0 |
Cash used in financing activities | -295.03M | 1.98B | 551.07M | 564.67M | 25.60M | 639.17M | 20.08M | 10.02M | 214.06M |
Net Change In Cash | 3.38M | -3.67B | -766.21M | 471.75M | 352.17M | 1.08B | 216.36M | -66.83M | 212.61M |
Cash at end of period | 140.69M | 6.66B | 1.50B | 2.27B | 1.80B | 1.45B | 369.52M | 153.15M | 219.98M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |